{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:46:21Z","timestamp":1779889581799,"version":"3.53.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T00:00:00Z","timestamp":1447891200000},"content-version":"vor","delay-in-days":1327,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1038\/ki.2011.444","type":"journal-article","created":{"date-parts":[[2012,1,18]],"date-time":"2012-01-18T13:13:07Z","timestamp":1326892387000},"page":"698-706","source":"Crossref","is-referenced-by-count":70,"title":["Comparative effectiveness of incident oral antidiabetic drugs on kidney function"],"prefix":"10.1016","volume":"81","author":[{"given":"Adriana M.","family":"Hung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christianne L.","family":"Roumie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Greevy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xulei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos G.","family":"Grijalva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey J.","family":"Murff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T Alp","family":"Ikizler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie R.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2011.444_bb0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.ki.5002343","article-title":"Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes","volume":"72","author":"Levey","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.444_bb0015","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2009.10.009","article-title":"Excerpts from the US renal data system 2009 annual data report","volume":"55","author":"Collins","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2011.444_bb0020","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.444_bb0025","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/bmj.39001.657755.BE","article-title":"Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey","volume":"333","author":"Hallan","year":"2006","journal-title":"BMJ"},{"key":"10.1038\/ki.2011.444_bb0030","first-page":"461","article-title":"Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy","volume":"14","author":"Brocco","year":"2001","journal-title":"J Nephrol"},{"key":"10.1038\/ki.2011.444_bb0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.444_bb0040","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2337\/diacare.23.10.1478","article-title":"Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. veterans affairs cooperative study on glycemic control and complications in type 2 diabetes feasibility trial investigators","volume":"23","author":"Levin","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1038\/ki.2011.444_bb0045","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.444_bb0050","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.444_bb0055","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.444_bb0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.jhh.1001444","article-title":"Rosiglitazone reduces urinary albumin excretion in type II diabetes","volume":"17","author":"Bakris","year":"2003","journal-title":"J Hum Hypertens"},{"key":"10.1038\/ki.2011.444_bb0065","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1097\/01.hjh.0000244955.39491.88","article-title":"Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria","volume":"24","author":"Bakris","year":"2006","journal-title":"J Hypertens"},{"key":"10.1038\/ki.2011.444_bb0070","doi-asserted-by":"crossref","first-page":"602","DOI":"10.7326\/0003-4819-154-9-201105030-00336","article-title":"Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations","volume":"154","author":"Bennett","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2011.444_bb0075","series-title":"Am Soc Nephrol","article-title":"Comparative effectiveness of incident oral antidiabetic drugs on kidney function in veterans with type 2 diabetes mellitus","author":"Hung","year":"2010"},{"key":"10.1038\/ki.2011.444_bb0080","doi-asserted-by":"crossref","first-page":"386","DOI":"10.7326\/0003-4819-147-6-200709180-00178","article-title":"Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus","volume":"147","author":"Bolen","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2011.444_bb0085","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/01.ASN.0000046029.53933.09","article-title":"Insulin resistance and risk of chronic kidney disease in nondiabetic US adults","volume":"14","author":"Chen","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.444_bb0090","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1046\/j.1523-1755.1998.00898.x","article-title":"Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease","volume":"53","author":"Fliser","year":"1998","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.444_bb0095","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1053\/j.ajkd.2004.09.034","article-title":"Insulin resistance in patients with chronic kidney disease","volume":"45","author":"Kobayashi","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2011.444_bb0100","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.2337\/dc08-0369","article-title":"Insulin sensitivity measured with euglycemic clamp is independently associated with glomerular filtration rate in a community-based cohort","volume":"31","author":"Nerpin","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1038\/ki.2011.444_bb0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2169\/internalmedicine.44.179","article-title":"Chronic kidney disease as a metabolic syndrome with malnutrition--need for strict control of risk factors","volume":"44","author":"Shoji","year":"2005","journal-title":"Intern Med"},{"key":"10.1038\/ki.2011.444_bb0110","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/ajcn\/86.5.1642","article-title":"Body mass index and fat mass are the primary correlates of insulin resistance in nondiabetic stage 3-4 chronic kidney disease patients","volume":"86","author":"Trirogoff","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1038\/ki.2011.444_bb0115","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1046\/j.1523-1755.2002.00600.x","article-title":"The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia","volume":"62","author":"Himmelfarb","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.444_bb0120","doi-asserted-by":"crossref","first-page":"882","DOI":"10.4049\/jimmunol.154.2.882","article-title":"Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes","volume":"154","author":"Descamps-Latscha","year":"1995","journal-title":"J Immunol"},{"key":"10.1038\/ki.2011.444_bb0125","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1097\/01.ASN.0000146422.45434.35","article-title":"Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals","volume":"15","author":"Fried","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.444_bb0130","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.amjmed.2005.07.060","article-title":"Cystatin-C and inflammatory markers in the ambulatory elderly","volume":"118","author":"Shlipak","year":"2005","journal-title":"Am J Med"},{"key":"10.1038\/ki.2011.444_bb0135","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1523-1755.2005.00398.x","article-title":"Biomarkers of inflammation and progression of chronic kidney disease","volume":"68","author":"Tonelli","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.444_bb0140","first-page":"661","article-title":"Insulin resistance in chronic kidney disease: its clinical characteristics and prognosis significance","volume":"30","author":"Caravaca","year":"2010","journal-title":"Nefrologia"},{"key":"10.1038\/ki.2011.444_bb0145","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ki.2010.11","article-title":"Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway","volume":"77","author":"Morales","year":"2010","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.444_bb0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1681\/ASN.2007080837","article-title":"Acute kidney injury increases risk of ESRD among elderly","volume":"20","author":"Ishani","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.444_bb0155","doi-asserted-by":"crossref","first-page":"520","DOI":"10.2215\/CJN.06711208","article-title":"The nexus of acute kidney injury, chronic kidney disease, and World Kidney Day 2009","volume":"4","author":"Okusa","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.444_bb0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-144-1-200601030-00006","article-title":"Body mass index and risk for end-stage renal disease","volume":"144","author":"Hsu","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2011.444_bb0165","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/sj.ijo.0801846","article-title":"Associations between weight gain and incident hypertension in a bi-ethnic cohort: the atherosclerosis risk in communities study","volume":"26","author":"Juhaeri J","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1038\/ki.2011.444_bb0170","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1046\/j.1523-1755.2001.0590041498.x","article-title":"Obesity-related glomerulopathy: an emerging epidemic","volume":"59","author":"Kambham","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.444_bb0175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00125-008-1157-y","article-title":"Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the american diabetes association and the european association for the study of diabetes","volume":"52","author":"Nathan","year":"2009","journal-title":"Diabetologia"},{"key":"10.1038\/ki.2011.444_bb0180","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.2215\/CJN.02250409","article-title":"Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis","volume":"4","author":"Navaneethan","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.444_bb0185","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1681\/ASN.2006080917","article-title":"Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up","volume":"17","author":"Navarro-Diaz","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.444_bb0190","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/pds.2035","article-title":"Glycemic and weight changes after persistent use of incident oral diabetes therapy: a veterans administration retrospective cohort study","volume":"19","author":"Huizinga","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1038\/ki.2011.444_bb0195","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-Year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.444_bb0200","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.2337\/db10-1392","article-title":"Effects of rosiglitazone, glyburide, and metformin on {beta}-cell function and insulin sensitivity in ADOPT","volume":"60","author":"Kahn","year":"2011","journal-title":"Diabetes"},{"key":"10.1038\/ki.2011.444_bb0205","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.2337\/diacare.21.12.2135","article-title":"Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy","volume":"21","author":"Imano","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1038\/ki.2011.444_bb0210","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1053\/meta.2001.26703","article-title":"Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria","volume":"50","author":"Nakamura","year":"2001","journal-title":"Metabolism"},{"key":"10.1038\/ki.2011.444_bb0215","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2215\/CJN.09291010","article-title":"Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy","volume":"6","author":"Lachin","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.444_bb0220","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1038\/ki.2011.444_bb0225","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/pds.2029","article-title":"The effect of incident antidiabetic regimens on lipid profiles in veterans with type 2 diabetes: a retrospective cohort","volume":"20","author":"Roumie","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1038\/ki.2011.444_bb0230","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0272-6386(98)70074-5","article-title":"Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey","volume":"32","author":"Jones","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2011.444_bb0235","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-131-4-199908170-00008","article-title":"Pharmacologic therapy for type 2 diabetes mellitus","volume":"131","author":"DeFronzo","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2011.444_bb0240","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/aje\/kwp151","article-title":"Defining incident chronic kidney disease in the research setting: The ARIC Study","volume":"170","author":"Bash","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1038\/ki.2011.444_bb0245","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/0197-2456(91)90069-X","article-title":"Design and statistical issues of the modification of diet in renal disease trial. the modification of diet in renal disease study group","volume":"12","author":"Beck","year":"1991","journal-title":"Control Clin Trials"},{"key":"10.1038\/ki.2011.444_bb0250","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2215\/CJN.03350708","article-title":"Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D)","volume":"4","author":"Fried","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.444_bb0255","series-title":"Hospital VA Information Resource Center","article-title":"VIReC technical report 2: VA NDI mortality data merge project","author":"Arnold","year":"2006"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815553660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815553660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T15:11:59Z","timestamp":1686669119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815553660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0085253815553660"],"URL":"https:\/\/doi.org\/10.1038\/ki.2011.444","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717597906.793052810","asserted-by":"object"}]},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}